Showing results (71-80 of 150) with videos related to
Sort By:
Pageof 15
Neuron|August 19, 2007
RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTASOyinkan A Sofola, Peng Jin, Yunlong Qin, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 30, 2011
FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124Xia-Lian Xu, Ruiting Zong, Zhaodong Li, et al.Human Molecular Genetics|November 27, 2018
Metabolic pathways modulate the neuronal toxicity associated with fragile X-associated tremor/ataxia syndromeHa Eun Kong, Junghwa Lim, Feiran Zhang, et al.The Journal of Pharmacology and Experimental Therapeutics|October 14, 2006
Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1David B Wainscott, Sheila P Little, Tinggui Yin, et al.The Journal of Clinical Investigation|May 3, 2003
Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblingsTaizo Wada, Akihiro Konno, Shepherd H Schurman, et al.Human Molecular Genetics|October 11, 2013
Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of fragile X-associated tremor/ataxia syndromeBing Yao, Li Lin, R Craig Street, et al.Journal of Pediatric Hematology/Oncology|June 26, 2004
Confirming or excluding the diagnosis of Wiskott-Aldrich syndrome in children with thrombocytopenia of an unknown etiologyTadashi Ariga, Masaru Nakajima, Jukei Yoshida, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 19, 2005
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding propertiesDavid B Wainscott, Joseph H Krushinski, James E Audia, et al.Neuron|June 28, 2002
Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brainJoannella Morales, P Robin Hiesinger, Andrew J Schroeder, et al.Cephalalgia : an International Journal of Headache|September 22, 2010
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditanDavid L Nelson, Lee A Phebus, Kirk W Johnson, et al.Pageof 15